Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation
Status:
Completed
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
This study investigated whether initiation of everolimus together with reduction of
calcineurin inhibitors (CNI) in maintenance heart or lung transplant patients with renal
impairment would improve renal function.